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their perceptions of the ultrasonographic characteristics of 
renal dysplasia and further tests that they might undertake.
Results Of almost 1200 physicians who successfully 
received the invitation, 248 from 54 countries completed 
the survey. There was a notable lack of homogeneity 
regarding the ultrasonographic diagnosis of renal dysplasia 
and also of follow-up tests, including genetic testing and 
further radiology.
Conclusions Based on the responses to this large survey, 
a picture emerges of nephrologists’ current clinical practice 
with regard to renal dysplasia. The Working Group consid-
ers that these results serve as an important sounding board 
which can provide the basis for more definitive recommen-
dations regarding the challenges to clinical diagnosis and 
diagnostic follow-up of this important condition.
Keywords Renal dysplasia · Chronic kidney disease · 
CAKUT · Children · Ultrasonography · Genetic testing
Introduction
The Miller-Keane Encyclopedia and Dictionary of Medi-
cine defines dysplasia as an abnormal tissue development 
caused by alteration in the size, shape and organization of 
mature cells [1]. In particular, renal dysplasia (RD), which 
can be either uni- or bilateral, is a congenital disorder, char-
acterized by abnormal differentiation in the renal paren-
chyma, histologically defined by the presence of primitive 
ducts and nests of metaplastic cartilage [2, 3]. Renal hypo-
plasia is conversely characterized by a reduced number of 
nephrons, in a small kidney (below −2SD), with normal 
renal architecture. Formally, RD is defined by histological 
parameters. However, to perform a kidney biopsy in every 
suspected case of RD is not feasible. Thus, in everyday 
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nephrology practice, imaging plays a major role in the 
diagnosis of these malformations.
Renal dysplasia is part of the spectrum of congenital 
anomalies of the kidney and urinary tract (CAKUT). It can 
occur isolated or as part of a syndrome. Isolated CAKUT 
can run in families. The clinical picture incorporates a wide 
and varied spectrum of manifestations, depending on the 
number of kidneys involved, the severity of dysplasia, the 
time at diagnosis and the presence or absence of oligohy-
dramnios. Unilateral forms (incidence 1:1000–5000) are 
usually asymptomatic and incidentally diagnosed during 
abdominal pre- and postnatal ultrasonography [4]; patients 
with bilateral forms (incidence 1:5000–10,000) are at risk 
of decreased renal function and end-stage renal disease 
and these forms are often associated with urologic malfor-
mations, such as dilating vesicoureteral reflux or urethral 
valves. Renal dysplasia is considered to represent the most 
common cause of chronic kidney disease (CKD) in pediat-
ric registries [5, 6], and children with RD are frequently the 
object of trials, the outcomes of which carry potential clini-
cal implications for this population [7].
Despite the fact that most cases of RD do not appear 
to be familial, mutations in several genes such as 
TCF2/HNF1B (mostly), PAX2, EYA1, SIX1 and SALL1 
have been identified. For example, the ESCAPE consor-
tium evaluated the prevalence of gene mutations in children 
with overtly non-syndromic RD and detected alterations in 
16% of index cases [8]. These genes encode for transcrip-
tion factors and related molecules critical for early renal 
development, and their mutations are sometimes associated 
with complex clinical syndromes.
The European Society for Pediatric Nephrology (ESPN) 
Working Group on Congenital Anomalies of the Kidney 
and Urinary Tract hypothesized that the current diagnostic 
approach with regard to renal dysplasia was not homoge-
neous. We were also mindful of the observation that the 
appearance of kidneys on ultrasound (US) scanning is often 
currently used as a basis for the diagnosis of RD. Accord-
ingly, we here report the results of a survey targeting pedi-
atric nephrologists with 12 questions regarding their per-
ceptions of the ultrasonographic characteristics of renal 
dysplasia and further tests that they might undertake.
Materials and methods
The survey was conducted on the Survey Monkey platform 
(https://www.surveymonkey.com) in the form of a ques-
tionnaire with 12 questions regarding the definition, diag-
nosis, imaging and genetic testing of RD. A letter explain-
ing the questionnaire and the rationale behind it was sent to 
the mailing list of the ESPN on two different dates between 
2014 and 2015. The questions and possible answers are 
listed in the following tables. They cover three principal 
topics: Table  1: diagnosis (questions 1–3); Table  2: man-
agement (questions 4–7); Table  3: genetics (questions 
8–12).
Results
Of almost 1200 physicians who successfully received the 
invitation, 248 from 54 countries completed the survey. 
Most of them were Pediatric Nephrologists (87%) from 
European countries, in particular: 51 from Turkey, 25 from 
Italy, 19 from the UK, 17 from Germany.
Definition and diagnosis
The responders’ definition of dysplasia is shown in Fig. 1. 
More than 1 answer was possible for this question. While 
an increased parenchymal echogenicity in a small kidney 
represents the most commonly selected option, followed by 
increased parenchymal echogenicity in kidneys with cysts, 
Table 1  Definition and 
diagnosis: questions 1–3 1. Is the presence of small kidneys necessary for the diagnosis of dysplasia?
 a. Yes
 b. No
2. Is the presence of hyperechogenicity necessary for the diagnosis of dysplasia?
 a. Yes
 b. No
3. Which of the following definitions represent a typical diagnosis of renal dysplasia in your opinion? 
(more than one answer is possible)
 a. Small bilateral kidneys
 b. Small unilateral kidney
 c. Increased renal parenchymal echogenicity in a small kidney
 d. Increased renal parenchymal echogenicity in a big kidney
 e. Increased renal parenchymal echogenicity in kidneys with cysts
 f. Other
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more than 60% of responders declared that small kidneys 
(unilateral or bilateral) were a typical sign of RD. This 
tendency was also confirmed in question 2, where almost 
a quarter of responders affirmed that the finding of small 
kidneys was necessary for a diagnosis of RD. In ques-
tion 3, 58% of responders answered that the presence of 
hyperechogenicity was not necessary for the diagnosis of 
dysplasia.
Table 2  Imaging: questions 4–7
4. When would you recommend further imaging in children with a diagnosis of renal dysplasia within the first year of life? (more than one 
answer is possible)
 a. Both kidneys affected
 b. Both kidneys affected and presence of oligohydramnios
 c. One kidney affected in association with dilation of the urinary tract
 d. Both kidneys affected and abnormal renal function
 e. One very small kidney affected with no dilation of the urinary tract
5. What further imaging would you suggest? (more than one answer is possible)
 a. Voiding cystourethrography
 b. DMSA scan
 c. MRI
 d. CT scan
6. In a child with bilateral renal dysplasia would you suggest sonographic screening of the first degree relatives?
 a. Yes
 b. No
7. In a child with unilateral renal dysplasia would you suggest sonographic screening of the first degree relatives?
 a. Yes
 b. No
Table 3  Genetics: questions 
8–12 8. In a child with unilateral renal dysplasia would you suggest genetic screening?
 a. Yes
 b. No
9. In a child with bilateral renal dysplasia would you suggest genetic screening?
 a. Yes
 b. No
10. In a child with unilateral cystic renal dysplasia would you suggest genetic screening?
 a. Yes
 b. No
11. In a family with bilateral cystic renal dysplasia would you suggest genetic screening?
 a. Yes
 b. No
12. Which genes would you screen in a family with bilateral renal dysplasia and other urologic anomalies 
and or extra-renal manifestations?
 a. HNF1β
 b. PAX2
 c. EYA1
 d. SIX1
 e. Whole exome sequencing
 f. Other
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Imaging
As we can see from the responses to question 4 (Fig.  2), 
most physicians agreed on recommending further imaging 
in the majority of cases, with the highest percentage pre-
scribing further imaging in children with urinary tract dila-
tion. The presence of oligohydramnios was also considered 
a risk factor requiring further imaging, as it is suggestive 
of posterior urethral valves in males. The preferred imag-
ing exams were voiding cystourethrography (VCUG) and 
dimercaptosuccinic acid (DMSA) scanning, while a minor-
ity of responders preferred to perform magnetic resonance 
imaging (MRI) or a computed tomography (CT) scan 
(Fig. 2).
Due to the documented familial occurrence of RD, we 
raised the question of imaging screening for the relatives 
Fig. 1  Definition of renal 
dysplasia
A – Small bilateral kidneys 66 %
B – Small unilateral kidneys 61 %
C – Increased renal parenchymal echogenicity in a small kidney 85 %
D – Increased renal parenchymal echogenicity in a big kidney 32 %
E – Increased renal parenchymal echogenicity in kidneys with cysts 80 %
F - Other 6 %
(More than one answer was possible)
Fig. 2  Imaging of renal dys-
plasia
A – Both kidneys affected 70 %
B – Both kidneys affected and 
presence of oligohydramnios
74 %
C – One kidney affected in 
associaon with dilaon of urinary 
tract
85 %
D – Both kidneys affected and 
abnormal renal funcon
78 %
E – One very small kidney affected 
with no dilaon of the urinary tract
53 %
(More than one answer was possible)
A – Voiding cystourethrography 81 %
B – DMSA Scan 83 %
C – MRI 16 %
D – CT Scan 7 %
(More than one answer was possible)
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of affected children. The responders were more likely to 
perform US screening in relatives of children affected by 
bilateral RD (over 70%) than in unilateral RD (less than 
40%) (questions 6 and 7).
Genetics
Responders would be more inclined to perform genetic 
screening in children affected by bilateral RD (60%) 
rather than in those with unilateral RD (19%) (questions 8 
and 9), and similar percentages were found for the cystic 
forms of RD, with a lesser tendency to perform further 
genetic testing in cases of unilateral RD when extra-renal 
Fig. 3  Genetics of renal dyspla-
sia A – Yes 15 %
B – Yes, depending on the kind of extra-renal 
symptoms
35 %
C – No 50 %
A – Yes 83 %
B – No 17 %
Fig. 4  Genetics of renal dyspla-
sia
A – HNF1B 70 %
B – PAX2 71 %
C – EYA1 41 %
D – SIX1 26 %
E – Whole exome sequencing 21 %
F - Other 17 %
(More than one answer was possible)
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manifestations were present (questions 10 and 11) (Fig. 3). 
The genes that responders would most frequently screen 
were TCF2/HNF1B and PAX2 (70 and 71%, respectively) 
followed by EYA1 and SIX1, while more than 20% of 
responders suggested whole exome sequencing (question 
12) (Fig. 4).
Discussion
The survey showed that there is a total lack of homogeneity 
among pediatric nephrologists as far as the diagnosis and 
management of children affected by RD are concerned.
Diagnosis
The only diagnostic criterion reported in the literature is 
histological and not feasible in clinical practice. As regards 
clinical practice and also research, it is essential to have a 
universally accepted definition of renal dysplasia for more 
than one reason. Firstly, since dysplasia represents the most 
common cause of CKD in children, it is important to diag-
nose it correctly; secondly, when classifying these condi-
tions in registries or when reporting on the progression of 
the disease or on results of interventional studies, it is vital 
that everybody starts from the same point, which is a diag-
nosis based on the same set of criteria.
Parenchymal hyperechogenicity, regardless of whether it 
is associated to a loss of cortico-medullary differentiation, 
is the only US feature that differentiates RD from simple 
renal hypoplasia and it is essential for a diagnosis of RD. 
Once other causes of increased renal echogenicity (such as 
congenital nephrotic syndrome, polycystic kidney disease, 
glycogen storage disease, nephronophthisis and oxalosis) 
have been excluded, parenchymal hyperechogenicity could 
suggest a diagnosis of RD in an infant or young child. This 
is an important indicator, as a kidney biopsy is neither clin-
ically nor ethically indicated. Having said that, US alone 
cannot be considered the bedrock for a diagnosis of RD per 
se, as there has never been a study reported in the literature 
that correlates postnatal US or other radiology images with 
definitive histology of dysplasia. Instead, a clinical diag-
nosis of RD should be based on a whole suite of available 
clinical data. If antenatal scans are also abnormal, a diag-
nosis of RD is quite likely, but if they are normal, the diag-
nosis becomes less so. If antenatal scans are not available, 
then the following criteria must be carefully examined: the 
perinatal history (e.g. an abnormal kidney due to prematu-
rity or renal vein thrombosis); the early childhood history 
(e.g. severe urosepsis may point to acquired kidney scar-
ring in a small kidney, or the presence of severe hyperten-
sion may point to a small kidney with renal artery stenosis); 
the family history which may include RD (or things which 
may look similar on postnatal US such as nephronophthi-
sis); and the use of genetic testing. When no hyperecho-
genicity shows up on US, then a diagnosis of RD cannot 
be made. When advanced CKD is present, a diagnosis of 
bilateral RD is impossible to confirm, because with the late 
stages of kidney damage the anatomical features are simi-
lar for a range of diseases. Small kidneys can be present 
in association with hyperechogenicity, consistent with renal 
hypo-dysplasia.
Imaging
Due to the lack of guidelines and recommendations in the 
literature, imaging in children affected by RD is an open 
field of debate. Renal dysplasia is often associated with 
urinary tract abnormalities, most commonly vesicoureteral 
reflux (VUR) and posterior urethral valves [5], and can 
sometimes be a consequence of obstructive uropathy in 
utero [9, 10]. The ESPN panel believes that a more thought-
ful and specific approach is needed in order to detect par-
ticularly correctable malformations of the urinary tract, 
especially obstructions, and manage and follow-up children 
with VUR in accordance with local guidelines. Therefore, 
in our clinical experience, further imaging, such as VCUG, 
DMSA scanning and indirect cystography with mercapto-
acetyltriglycine (MAG3), could be beneficial only in chil-
dren with bilateral or unilateral RD in association with 
clinical symptoms such as urinary tract infections or major 
dilations of the urinary tract, especially of the ureter.
Imaging investigation in families of children affected 
by RD is an intriguing aspect, and we agree that it would 
be beneficial to perform US screening in first degree rela-
tives of children with non-obstructive bilateral RD—in 
other words, in those without abnormalities of the urinary 
tract—in order to detect unrecognized and asymptomatic 
cases. US screening of first degree relatives seems useful, 
as the economic cost is relatively low with no radiation bur-
den, while the clinical usefulness of RD diagnosis is rel-
evant in allowing for an ad-hoc follow-up. Furthermore, 
US screening of siblings and parents can be helpful in try-
ing to identify specific hereditary patterns within affected 
families. Extended fetal renal ultrasound screening in new 
pregnancies of parents with affected children could also be 
of value.
Genetics
The genetic aspect of RD is currently a hot topic in 
the literature. The significant improvements in genome 
scanning technologies, such as next generation sequenc-
ing, have enabled the study of large areas of DNA from 
affected children in an attempt to unravel the genetic 
background of this condition. Over the last few years, 
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mutations in many genes have been associated with 
non-obstructive RD. Some of these are included in com-
plex clinical syndromes such as branchio-oto-renal syn-
drome (EYA1, SIX1), renal-coloboma syndrome (PAX2), 
renal cysts and diabetes syndrome (TCF2/HNF1B) 
and Townes–Brocks syndrome (SALL1). However, the 
majority of RD cases are non-syndromic, oligogenic 
or polygenic disorders, which do not follow Mende-
lian inheritance and may occur sporadically [11, 12]. 
The numbers of genes involved in non-syndromic RD 
is constantly growing and particular attention has been 
focused on hepatocyte nuclear factor 1-beta (HNF1B) 
mutations, which have been described as the main cause 
of bilateral hyperechogenic kidneys at prenatal US [13]. 
HNF1B encodes a transcriptional factor involved in the 
development of several tissues, including that of the 
kidney and urinary tract, pancreas and others [14]. The 
most common pathological expressions of HNF1B muta-
tions are renal cysts associated with early onset diabe-
tes. Twenty-five percent of patients with bilateral cystic 
RD carry an HNF1B mutation [14]. Therefore, it seems 
reasonable to study mutations of HNF1B in these chil-
dren, especially when cysts are found in association with 
hyperechogenicity. Major clinical implications from this 
genetic diagnosis derive from the fact that mutations in 
this gene may cause noninsulin-dependent diabetes mel-
litus later in life and that it is inherited as an autosomal 
dominant trait. Recently, a score system has been pro-
posed to select patients that should be tested for HFN1B 
mutations, showing good results [15]. As there is a lim-
ited genotype-phenotype correlation, familial screening 
of HNF1B should be proposed when mutations have 
been identified in the index patient, in order to offer 
adequate genetic counselling [16]. However, given the 
contentious nature of screening siblings of affected chil-
dren due to medical and psychological implications, cau-
tion is needed and genetic testing should only be offered 
to families deemed responsible enough to deal with the 
eventual results. The potential influence on life insur-
ance policies is something that also needs to be taken 
into consideration.
A more extensive genetic screening (gene panel diag-
nostics or whole exome screening) could be useful in 
patients with severe syndromic disease with multior-
gan manifestations or when a differential diagnosis is 
required, e.g. between nephronophthisis and renal hypo-
dysplasia (RHD), which can be very hard to separate 
on clinical grounds, and/or for research purposes. In 
the near future, when gene panel testing becomes rou-
tinely available, a relatively large number of genes will 
be tested at low cost and this will change the scenario, 
allowing a more in-depth genetic testing in clinical 
practice.
Limitations of the study
All the data reported and discussed derive from an on-
line survey, addressed to European pediatric nephrolo-
gists, with no contribution being made by other profes-
sionals, who could be involved in the diagnosis and care 
of children with renal dysplasia. Furthermore, only 20% 
of the pediatric nephrologists contacted about the sur-
vey by mail responded to the survey, and therefore they 
represent a partial and not fully representative sample. 
Another limitation of the study relates to the fact that 
some of the questions dealing with the diagnostic process 
adopted by pediatric nephrologists following a diagno-
sis of renal dysplasia allowed for multiple answers, and 
this could have led to some difficulty in interpreting the 
responses.
Conclusion
In summary, bearing in mind the above-mentioned limita-
tions, this survey clearly unveils the heterogeneity of diag-
nostic measures and management of RD among specialists 
throughout Europe. As Pediatric Nephrologists and other 
specialists with expertise in the field, from different coun-
tries, we believe in the importance of establishing widely 
accepted general guidelines. This will improve the quality 
of care for children with RD who are at risk of developing 
chronic renal insufficiency and end-stage renal disease.
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